December 12, 2022
ChroniSense Medical Ltd. took a step towards its vision of transforming chronic care management with Polso™, the company’s Remote Patient Monitoring (RPM) solution, achieving 510(k) clearance from the U.S. Food and Drug Administration (FDA). Initial...
Read More »
May 10, 2022
ChroniSense Medical welcomes Liz Kwo, MD, MBA, MPH to its Board of Directors as the company’s first independent board director. Dr. Kwo brings extensive clinical, entrepreneurial and leadership experience to the ChroniSense board, as founder and executive of...
Read More »
January 12, 2021
ChroniSense Medical comments on trends in remote patient monitoring and how Polso™ plays role in the transformation of healthcare.
Read More »
November 4, 2020
ChroniSense's CEO Bridget Ross presents the Polso™ watch to the MassMEDIC Medtech Showcase
Read More »
March 19, 2020
Bridget Ross, a seasoned healthcare executive, Board Director, and company Advisor has been appointed CEO of ChroniSense Medical.
Read More »
September 20, 2019
Polso™ watch is being used in the first clinical validation study of a wearable device that measures all National Early Warning Score (NEWS) parameters in a hospital setting.
Read More »